When the Covid-19 pandemic hit, the then-Stanford professor was one of the loudest critics of lockdowns, school closures and ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

The head of the U.S. Food and Drug Administration on Tuesday reportedly raised doubts about the need for COVID booster shots ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Novavax sees pathway to FDA approval after post-marketing commitments ... investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway ...

(Reuters) - Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway to resolving issues with ...

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.